| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/24/2012 | WO2012068537A2 New biocatalysts and primers for production of chemicals |
| 05/24/2012 | WO2012068519A2 Markers associated with response to activated protein c administration, and uses thereof |
| 05/24/2012 | WO2012068511A2 Method for amplification-free nucleic acid detection on optofluidic chips |
| 05/24/2012 | WO2012068468A1 Method of treatment with braf inhibitor |
| 05/24/2012 | WO2012068446A1 Viability cell counting by differential light absorption |
| 05/24/2012 | WO2012068400A2 Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
| 05/24/2012 | WO2012068392A2 Low cost, portable sensor for molecular assays |
| 05/24/2012 | WO2012068383A2 ncRNA AND USES THEREOF |
| 05/24/2012 | WO2012068339A2 Methods of treating cancer |
| 05/24/2012 | WO2012068288A2 Diagnosing and monitoring cns malignancies using microrna |
| 05/24/2012 | WO2012068287A2 System for identifying and sorting living cells |
| 05/24/2012 | WO2012068245A1 Methods for identifying subjects at risk of developing psychiatric disorders during interferon-alpha treatment |
| 05/24/2012 | WO2012068232A1 Aurora a kinase effectors |
| 05/24/2012 | WO2012068170A2 Generation of neural stem cells from human trophoblast stem cells |
| 05/24/2012 | WO2012068107A2 Autoantibody to rna-protein complex detected by quantitative pcr |
| 05/24/2012 | WO2012068003A2 Particle focusing systems and methods |
| 05/24/2012 | WO2012067970A2 Transcriptional repression leading to parkinson's disease |
| 05/24/2012 | WO2012067925A1 Genetic loci associated with resistance of corn to fijivirus |
| 05/24/2012 | WO2012067911A1 Methods for sequencing a biomolecule by detecting relative positions of hybridized probes |
| 05/24/2012 | WO2012067901A1 Methods and kits for multiplex amplification of short tandem repeat loci |
| 05/24/2012 | WO2012067831A1 Real time cleavage assay |
| 05/24/2012 | WO2012067830A2 Methylation assay |
| 05/24/2012 | WO2012067828A1 Mutation detection assay |
| 05/24/2012 | WO2012067525A1 Genotypes and selenium level as a markers of breast/ovarian cancer risk in brca1 mutation carriers |
| 05/24/2012 | WO2012067465A2 Automatic necleic acid purification apparatus and method for aerosol-protecting |
| 05/24/2012 | WO2012067460A2 Method for screening for materials for promoting the differentiation of skin cells |
| 05/24/2012 | WO2012067450A2 Efemp1 gene as a diagnostic marker for prostate cancer |
| 05/24/2012 | WO2012067288A1 Preparation method of aptamer |
| 05/24/2012 | WO2012067259A1 Method for detecting low concentrations of specific cell from high concentrations of contaminating cell populations, and method for collecting and analyzing detected cell |
| 05/24/2012 | WO2012066582A1 Genetic risk factors of sick sinus syndrome |
| 05/24/2012 | WO2012066576A2 Oligonucleotide primer sequences for detection of leptospira |
| 05/24/2012 | WO2012066536A2 Transcriptome signatures discriminate etanercept-treated rheumatoid arthritis (ra) patients according to their response or refractory status |
| 05/24/2012 | WO2012066500A1 Flow-through apparatus |
| 05/24/2012 | WO2012066499A1 Flow-through apparatus |
| 05/24/2012 | WO2012066451A1 Prognostic and predictive gene signature for colon cancer |
| 05/24/2012 | WO2012066321A1 Biosensor and uses thereof |
| 05/24/2012 | WO2012066161A1 Glutamyl aminopeptidase as a marker of renal damage |
| 05/24/2012 | WO2012066141A1 Markers for acute kidney injury and uses thereof |
| 05/24/2012 | WO2012066121A1 Method for detecting nucleic acids |
| 05/24/2012 | WO2012065705A1 Novel complex mutation in the epidermal growth factor receptor kinase domain |
| 05/24/2012 | WO2012065480A1 Nanopore sensor of sub-nanometer thickness |
| 05/24/2012 | WO2012065231A1 Signal amplification |
| 05/24/2012 | WO2012065228A1 Pongamia genetic markers and method of use |
| 05/24/2012 | WO2012049465A8 Assay device |
| 05/24/2012 | WO2012046006A3 Cutaneous squamous cell carcinoma target sequences |
| 05/24/2012 | WO2012042211A3 Glucose electrochemical measurement method with error detection |
| 05/24/2012 | WO2012040500A3 Direct blood assay for detection of circulating microrna in cancer patients |
| 05/24/2012 | WO2012038831A3 A method for detecting, quantifying and mapping damage and/or repair of dna strands |
| 05/24/2012 | WO2012027617A3 Systems and methods for detecting normal levels of bacteria in water using a multiple angle light scattering (mals) instrument |
| 05/24/2012 | WO2012019000A3 Biomarkers for the identification monitoring and treatment of ovarian cancer |
| 05/24/2012 | WO2012018613A3 Genetic make-up modifies cancer outcome |
| 05/24/2012 | WO2012012797A3 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 05/24/2012 | WO2012012704A3 Methods of detecting kidney-associated diseases or conditions |
| 05/24/2012 | WO2012012510A3 Gene expression profiling for the identification of lung cancer |
| 05/24/2012 | WO2012011778A3 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer |
| 05/24/2012 | WO2012011777A3 Kit for diagnosing colorectal cancer and pharmaceutical composition for prevention or treatment of colorectal cancer |
| 05/24/2012 | WO2012009547A3 Biomarkers for diagnosis of transient ischemic attacks |
| 05/24/2012 | WO2012009499A3 Assessing thyroid neoplasms and treating cancer |
| 05/24/2012 | WO2011156690A3 Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates |
| 05/24/2012 | US20120131692 Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof |
| 05/24/2012 | US20120131690 Brassica gat event dp-061061-7 and compositions and methods for the identification and/or detection thereof |
| 05/24/2012 | US20120130648 Determination of the risk of distant metastases in surgically treated patients with non-small cell lung cancer in stage i-iiia |
| 05/24/2012 | US20120129957 Analyzing the fmr1 gene |
| 05/24/2012 | US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics |
| 05/24/2012 | US20120129901 Triterpenoid derivatives useful as antiproliferative agents |
| 05/24/2012 | US20120129880 Method for determining sensitivity to irinotecan and use thereof |
| 05/24/2012 | US20120129869 Phosphorylation and mutations of anaplastic lymphoma kinase as a diagnostic and therapeutic target in lung cancer |
| 05/24/2012 | US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation |
| 05/24/2012 | US20120129835 Schizophrenia methods and compositions |
| 05/24/2012 | US20120129805 Barley and uses thereof |
| 05/24/2012 | US20120129794 Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy |
| 05/24/2012 | US20120129788 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
| 05/24/2012 | US20120129782 Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders |
| 05/24/2012 | US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides |
| 05/24/2012 | US20120129725 Nucleic acid nano-biosensors |
| 05/24/2012 | US20120129724 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
| 05/24/2012 | US20120129714 Quantitative multiplexed identification of nucleic acid targets |
| 05/24/2012 | US20120129711 Biomarkers for the prognosis and high-grade glioma clinical outcome |
| 05/24/2012 | US20120129706 Method of Assessing Soil Quality and Health |
| 05/24/2012 | US20120129705 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
| 05/24/2012 | US20120129704 Generation of uniform fragments of nucleic acids using patterned substrates |
| 05/24/2012 | US20120129211 Titration of differentiation medium components |
| 05/24/2012 | US20120129210 Method for Assaying Inositol Hexaphosphate (IHP) |
| 05/24/2012 | US20120129209 Aligning cells on wrinkled surface |
| 05/24/2012 | US20120129208 Honeycomb shrink wells for stem cell culture |
| 05/24/2012 | US20120129207 Compositions and methods of functionally enhanced in vitro cell culture system |
| 05/24/2012 | US20120129206 Method of identifying patients suitable for high-dose cyclophosphamide treatment |
| 05/24/2012 | US20120129205 Novel Nitroreductase Enzymatic Substrates |
| 05/24/2012 | US20120129204 Novel nitroreductase enzymatic substrates |
| 05/24/2012 | US20120129203 Novel Peptidase Substrates |
| 05/24/2012 | US20120129202 Composition for assaying glycated proteins |
| 05/24/2012 | US20120129201 Mass spectrometry imaging with substance identification |
| 05/24/2012 | US20120129195 Method of quick laboratory diagnosis if illnesses based on the discovery of specific proteins and equipment for its implementation |
| 05/24/2012 | US20120129190 Ensemble-decision aliquot ranking |
| 05/24/2012 | US20120129189 Methods of Controlling Cell Proliferation |
| 05/24/2012 | US20120129187 Diagnostical use of peroxiredoxin 4 |
| 05/24/2012 | US20120129184 Systemic carnitine deficiency gene and uses thereof |
| 05/24/2012 | US20120129183 Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders |
| 05/24/2012 | US20120129182 Amplification of complex nucleic acids |
| 05/24/2012 | US20120129181 Detection of bacterial (mollicutes) contamination |